Table 1 Baseline patient characteristics.

From: Comparison of bipolar plasmakinetic resection of prostate versus photoselective vaporization of prostate by a three year retrospective observational study

Characteristic

Before PSM

After PSM

PVP group (n = 109)

PKRP group (n = 106)

P Value

PVP group (n = 60)

PKRP group (n = 60)

P Value

Age (year)

72.68 ± 6.95

67.47 ± 7.39

< 0.001

70.37 ± 6.09

71.12 ± 6.07

0.500

BMI (kg/m2)

21.93 ± 3.23

21.30 ± 3.16

0.146

21.68 ± 3.25

21.13 ± 3.12

0.341

PV (g)

63.19 ± 19.94

54.60 ± 21.00

0.002

59.40 ± 21.38

60.02 ± 20.33

0.872

tPSA (ng/ml)

5.18 ± 3.15

3.43 ± 2.48

< 0.001

4.07 ± 2.56

4.15 ± 2.64

0.856

IPSS

23.13 ± 3.80

21.74 ± 3.69

0.007

21.98 ± 4.30

22.92 ± 2.98

0.169

QoL

4.93 ± 0.65

4.79 ± 0.67

0.138

4.77 ± 0.70

4.97 ± 0.52

0.078

Qmax (ml/s)

6.63 ± 2.27

7.31 ± 2.40

0.034

7.24 ± 2.43

6.70 ± 1.84

0.176

PVR (ml)

84.06 ± 60.80

72.18 ± 59.87

0.150

72.32 ± 62.27

80.40 ± 55.78

0.455

IIEF-5

8.04 ± 1.67

8.96 ± 2.11

< 0.001

8.37 ± 1.79

8.27 ± 2.11

0.780

MSHQ

41.61 ± 18.98

48.38 ± 15.91

0.005

46.07 ± 17.59

43.10 ± 16.90

0.348

MSHQ-EjD

12.08 ± 5.02

14.16 ± 5.48

0.004

12.87 ± 5.21

12.00 ± 5.18

0.362

Charlson CI

  

0.035

  

0.678

0

42

49

 

27

22

 

1

37

42

 

18

26

 

2

21

14

 

9

12

 

3

9

1

 

6

0

 
  1. BMI body mass index, PV prostate volume, tPSA total prostate-specific antigen, IPSS international prostate symptom score, QoL quality of life score, Qmax maximal urinary flow rate, PVR postvoid residual, IIEF-5 international index of erectile function-five term score, MSHQ male sexual health questionnaire score, MSHQ-EjD male sexual health questionnaire on ejaculatory dysfunction score, Charlson CI charlson comorbidity index.
Back to article page